Drug & intervention
fluticasone
RxCUI 41126
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Fluticasone
Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. Both the esters, fluticasone propionate (sold as Flovent) and fluticasone furoate, are also used as topical anti-inflammatories and inhaled corticosteroids, and are used much more commonly in comparison. Fluticasone is on the World Health Organization's List of Essential Medicines. In 2023, it was the 26th most commonly prescribed medication in the United States, with more than 21 million prescriptions, although it is also sold over-the-counter (OTC).
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
26 shownData Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs FluticasoneNCT05457855 · 2022-02-01
COMPLETEDEffect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled AsthmaNCT02577497 · 2016-06-01
COMPLETEDStudy to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDNCT02055352 · 2014-05-30
COMPLETEDEffects of QVAR in Smokers With AsthmaNCT01741285 · 2013-04-01
COMPLETEDAirway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid TreatmentNCT01537133 · 2012-10-01
COMPLETEDInhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled AsthmaNCT01881412 · 2012-08-01
TERMINATEDA Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma PatientsNCT01202084 · 2012-01-01
COMPLETEDImpact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in SmokersNCT00908362 · 2009-05-01
COMPLETEDFluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate AsthmaNCT00830505 · 2009-04-01
COMPLETEDAdditive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory AsthmaNCT00829257 · 2009-01-01
COMPLETEDMethaCholine Bronchoprovocation Study (MeCIS)NCT00705341 · 2009-01-01
COMPLETEDRepeated High-dose Inhaled Corticosteroids for AsthmaNCT00695604 · 2008-05-01
WITHDRAWNA Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy VolunteersNCT00674050 · 2008-05-01
COMPLETEDShould Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?NCT00509197 · 2007-10-01
TERMINATEDEfficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPDNCT00535366 · 2007-10-01
COMPLETEDLeukotriene Receptor Antagonists or Steroids in Pre-School AsthmaNCT00543686 · 2007-08-01
COMPLETEDInteractive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the AirwayNCT01231230 · 2007-05-01
COMPLETEDExercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)NCT00387036 · 2006-12-01
TERMINATEDOpen-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaNCT00504062 · 2006-10-01
COMPLETEDResponsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)NCT00306163 · 2006-05-01
COMPLETEDEfficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic AsthmaNCT00079937 · 2004-04-01
COMPLETEDEffects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPDNCT02209974 · 2004-02-01
COMPLETEDThe Effect of Salmeterol on Eosinophil (EOS) FunctionNCT00214019 · 2003-11-01
COMPLETEDThe Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol TrialNCT00156819 · 2003-06-01
COMPLETEDDose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in AsthmaNCT00606242 · 2000-01-01
COMPLETEDInhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate AsthmaNCT00409630
WITHDRAWNConditions being studied
Research locations
ChicagoIllinois, United States5St LouisMissouri, United States4DenverColorado, United States3DurhamNorth Carolina, United States3MiamiFlorida, United States3AtlantaGeorgia, United States2BirminghamAlabama, United States2BostonMassachusetts, United States2BurlingtonVermont, United States2ColumbusOhio, United States2HoustonTexas, United States2IndianapolisIndiana, United States2
Leading sponsors
AstraZeneca2Novartis Pharmaceuticals2University of Dundee2Boehringer Ingelheim1Brigham and Women's Hospital1Eurofarma Laboratorios S.A.1Hospital Son Llatzer1JHSPH Center for Clinical Trials1Johann Wolfgang Goethe University Hospital1Johns Hopkins Bloomberg School of Public Health1Mannkind Corporation1Merck Sharp & Dohme LLC1Milton S. Hershey Medical Center1Rhode Island Hospital1Université de Montréal1
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.